Last Published 11.01.2025 Effective Date: 11.01.2025 This policy addresses alpha1-proteinase inhibitors (Aralast NP, Glassia, Prolastin-C, and Zemaira) for chronic augmentation and maintenance therapy of emphysema due to congenital deficiency of alpha1-proteinase inhibitor (A1-PI)/alpha1-antitrypsin (AAT) deficiency
Let me break down every common scenario
Naegle Law Firm (2022)
(2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) This article was reviewed and approved by Alice Fletcher, Lead Bariatric Dietitian, on 31 July 2025
doi:10.22074/cellj.2016.4872 [5] Tenrio MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF
once reconstituted, refrigerate at 28 C and do not freeze